Search research articles
Contact Us
Filters
Showing results (581-590 of 602) with videos related to
Page
of 61
Sort By:
The New England Journal of Medicine
|
December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Meletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
The Lancet. Haematology
|
February 3, 2022
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
Noopur S Raje, Elias Anaissie, Shaji K Kumar, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Page
of 61
Search research articles
Search
Showing results (581-590 of 602) with videos related to
Sort By:
Page
of 61
The New England Journal of Medicine
|
December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Meletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
The Lancet. Haematology
|
February 3, 2022
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
Noopur S Raje, Elias Anaissie, Shaji K Kumar, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Page
of 61